FDA campus consolidation revised budget of $810 mil. seeks reductions in design, engineering costs.
FDA CAMPUS: $80 MIL. GSA SCALE-BACK FOR CONSOLIDATION was greeted favorably by House Transportation & Infrastructure/ Public Buildings & Economic Development Subcommittee Chairman Rep. Gilchrest (R-Md.) at a March 6 hearing on the proposed budget for the agency's consolidated campus. "The original cost of the project was considerably larger than the current scope of this project," Gilchrest observed. The revised $810 mil. cost estimate is $80 mil. less than the agency's original projection of $890 mil. and half-a-billion dollars below initial 1990 estimates of $1.4 bil.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth